Why the study?
Does a round cell component of > 5% increase the risk of metastasis or death in patients with myxoid liposarcoma of the extremities?
Does a round cell component of > 5% increase the risk of metastasis or death in patients with myxoid liposarcoma of the extremities?
A round cell component of > 5% in myxoid liposarcoma of the extremities portends a higher risk of metastasis or death from disease.
No takes yet. Share an insight, caveat, or question.
May refine prognostic stratification in myxoid liposarcoma; leaves open impact on therapy pending prospective validation.
Smith et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: